63 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud
424B5
ENLV
Enlivex Therapeutics Ltd
29 May 24
Prospectus supplement for primary offering
4:15pm
the sovereignty or security of the State of Israel;
the judgment was obtained by fraud;
the opportunity given to the defendant to bring its
6-K
EX-99.1
n8m6gez
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
3tobzxashqpfjb0m0x3
31 Mar 23
Report of Foreign Private Issuer
4:30pm
424B5
mkczoot5wwnve9xj33n9
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
4fnbnm9zkq2e7p gs32
29 Apr 22
Shelf registration (foreign)
8:14am
424B5
bsruv
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
yhsng
9 Feb 21
Prospectus supplement for primary offering
4:56pm